Back
Evotec SE 10K Form
Sell
22
EVO
Evotec SE
Last Price:
$3.2200
Seasonality Move:
5031.82%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive EVO News And Ratings
See the #1 stock for the next 7 days that we like better than EVO
EVO Financial Statistics
Sales & Book Value
| Annual Sales: | $862.1M |
|---|---|
| Cash Flow: | $-101.3M |
| Price / Cash Flow: | 100.09 |
| Annual Sales: | $2.65 |
| Price / Book: | 1.22 |
Profitability
| EPS (TTM): | -0.49680 |
|---|---|
| Net Income (TTM): | $-176.5M |
| Gross Margin: | $71.2M |
| Return on Equity: | -17.7% |
| Return on Assets: | -8.33% |
Evotec SE Earnings Forecast
Key Evotec SE Financial Ratios
-
The Gross Profit Margin over the past 28 years for EVO is 8.26%.
-
The Selling, General & Administrative Expenses for EVO have been equal to 23.61% of Gross Profit Margin.
-
The Research & Development expenses have been 12.15% of Revenue.
-
The Net Earning history of EVO is -24.60% of Total Revenues.
-
Per Share Earnings over the last 28 years have been positive in 12 years.
Evotec SE Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | EVO |
| Website: | evotec.com |
Debt
| Debt-to-Equity Ratio: | 0.61 |
|---|---|
| Current Ratio: | 2.12 |
| Quick Ratio: | 1.05 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |